Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
606.00    -7.00 (-1.14%)
Bid:
606.00
Ask:
608.00
Spread: 2.00 (0.33%)
Market Cap: £672.51m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Merger Update

14 Feb 2013 10:22

RNS Number : 8895X
Barr(A.G.) PLC
14 February 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For Immediate Release

14 February 2013

A.G. BARR p.l.c. ("A.G. Barr") and Britvic plc ("Britvic")

All-share merger update: decision to seek Competition Commission clearance

The Boards of A.G. Barr and Britvic refer to their joint announcement noting the decision by the Office of Fair Trading (the "OFT") to refer the proposed merger of A.G. Barr and Britvic (the "Merger") to the Competition Commission due to concerns that the Merger could reduce competition between certain brands of A.G. Barr and Britvic.

 

A.G. Barr and Britvic believe that the merger will not result in a substantial lessening of competition and that they will be able to demonstrate this to the Competition Commission. The Boards of A.G. Barr and Britvic therefore intend to work together with the Competition Commission during its investigation with a view to seeking clearance of the proposed merger. The Competition Commission's investigation is expected to take approximately six months. If clearance is received from the Competition Commission on terms satisfactory to both A.G. Barr and Britvic, the Boards of A.G. Barr and Britvic will each reconsider, at that time, the terms of a possible merger between A.G. Barr and Britvic. There can be no certainty or assurance that, following such clearance, any such merger would be forthcoming or that any offer will be made by either A.G. Barr or Britvic.

 

A.G. Barr and Britvic consider there to be compelling rationale for clearance. The view of the two Boards on the benefits of the transaction is unchanged and they continue to believe that it is in the interests of the two shareholder groups. A.G. Barr and Britvic will continue to work closely with the authorities to expedite clearance.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the Scheme Document dated 5 December 2012.

Enquiries

A.G. BARR p.l.c.

Roger White

Alex Short +44 (0) 1236 852 400

Rothschild (financial adviser to A.G. Barr)

Akeel Sachak

Stuart Vincent

Jessica Dale +44 (0) 207 280 5000

Investec Bank plc (broker to A.G. Barr)

Keith Anderson

David Anderson

Henry Reast +44 (0) 207 597 5970

College Hill (PR adviser to A.G. Barr)

Justine Warren

Matthew Smallwood +44 (0) 207 457 2020

Britvic plc

Gerald Corbett

John Gibney

Rupen Shah

Steve Nightingale +44 (0) 1442 284330

Citigroup Global Markets Limited

(joint financial adviser and joint broker to Britvic)

David Wormsley

Jan Skarbek

Andrew Seaton +44 (0) 207 986 4000

Nomura International plc

(joint financial adviser and joint broker to Britvic)

Nicholas Marren

Ed Matthews +44 (0) 207 521 2000

Brunswick (PR adviser to Britvic)

Mike Smith

Nick Cosgrove +44 (0) 207 404 5959

 

Rothschild, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as corporate broker to A.G. Barr and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than A.G. Barr for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Citigroup Global Markets Limited, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively for Britvic and for no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than Britvic for providing the protections afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Nomura International plc, which conducts its UK investment banking business as Nomura, is authorised and regulated in the United Kingdom by the FSA and is acting as joint broker and joint financial adviser to Britvic and for no-one else in connection with the matters set out in this announcement. Nomura will not be responsible to anyone other than Britvic for providing the protection afforded to its clients or for providing advice in connection with the matters set out in this announcement.

Publication on website

A copy of this announcement will be made available, free of charge, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Britvic's and A.G. Barr's websites at http://ir.britvic.comand www.agbarr.co.ukrespectively by no later than noon (London time) on the day following the date of this announcement. For the avoidance of doubt, the contents of those websites are not incorporated into and do not form part of this announcement.

You may request a hard copy of this announcement by contacting the Company Secretary of Britvic at company.secretariat@britvic.co.uk (or on +44(0)1442 284411) or by writing to Britvic plc, Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, or by contacting the Company Secretary of A.G. Barr at companysecretarialdepartment@agbarr.co.uk (or on +44(0)1236 852400) or by writing to A.G. BARR p.l.c., Westfield House, 4 Mollins Road, Cumbernauld, G68 9HD. You may also request that all future documents, announcements and information to be sent to you in relation to the Merger should be in hard copy form.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MERZMGMZGDMGFZM
Date   Source Headline
24th Jul 20191:36 pmRNSDirector/PDMR Shareholding - clarification
24th Jul 201910:44 amRNSDirector/PDMR Shareholding - replacement
24th Jul 20197:00 amRNSTransaction in Own Shares
23rd Jul 20199:38 amRNSDirector/PDMR Shareholding
23rd Jul 20199:37 amRNSDirector/PDMR Shareholding
16th Jul 20197:00 amRNSPre-close trading update
8th Jul 201911:39 amRNSDirector/PDMR Shareholding
11th Jun 20191:14 pmRNSDirector/PDMR Shareholding
11th Jun 20191:13 pmRNSDirector/PDMR Shareholding
10th Jun 201912:40 pmRNSDirector/PDMR Shareholding
10th Jun 201912:38 pmRNSDirector/PDMR Shareholding
10th Jun 201912:37 pmRNSDirector/PDMR Shareholding
10th Jun 201912:36 pmRNSDirector/PDMR Shareholding
10th Jun 201912:29 pmRNSDirector/PDMR Shareholding
7th Jun 20197:00 amRNSMinority investment in STRYYK
31st May 201912:42 pmRNSAGM Statement
29th May 20198:04 amRNSHolding(s) in Company
9th May 20193:58 pmRNSDirector/PDMR Shareholding
3rd May 20191:18 pmRNSDirector/PDMR Shareholding
17th Apr 20199:24 amRNSAnnual Report and Accounts and Notice of AGM
4th Apr 20193:25 pmRNSDirector/PDMR Shareholding
2nd Apr 20191:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20191:43 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSFinal Results
8th Mar 20191:11 pmRNSDirector/PDMR Shareholding
8th Mar 20199:36 amRNSHolding(s) in Company
15th Feb 20197:30 amRNSTransaction in Own Shares
8th Feb 20199:39 amRNSDirector/PDMR Shareholding
8th Feb 20197:30 amRNSTransaction in Own Shares
5th Feb 20197:30 amRNSTransaction in Own Shares
25th Jan 201912:25 pmRNSClosed period repurchase programme
25th Jan 20197:00 amRNSTrading Update
15th Jan 201910:48 amRNSNotice of Pre-Close Trading Update
9th Jan 201912:38 pmRNSDirector/PDMR Shareholding
10th Dec 20181:32 pmRNSDirector/PDMR Shareholding
8th Nov 201812:14 pmRNSDirector/PDMR Shareholding
29th Oct 201812:26 pmRNSDirector/PDMR Shareholding
29th Oct 201812:24 pmRNSDirector/PDMR Shareholding
29th Oct 201812:22 pmRNSDirector/PDMR Shareholding
29th Oct 201812:19 pmRNSDirector/PDMR Shareholding
25th Oct 20187:00 amRNSBoard Appointment
23rd Oct 20187:30 amRNSTransaction in Own Shares
17th Oct 20187:30 amRNSTransaction in Own Shares
16th Oct 20187:30 amRNSTransaction in Own Shares
12th Oct 20187:44 amRNSTransaction in Own Shares
10th Oct 20187:30 amRNSTransaction in Own Shares
8th Oct 20181:15 pmRNSDirector/PDMR Shareholding
8th Oct 20187:30 amRNSTransaction in Own Shares
5th Oct 20187:30 amRNSTransaction in Own Shares
4th Oct 20187:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.